Wird geladen...
Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
Alzheimer’s disease (AD) and treatment of the brain in aging require the development of new biologic drugs, such as recombinant proteins or gene therapies. Biologics are large molecule therapeutics that do not cross the blood-brain barrier (BBB). BBB drug delivery is the limiting factor in the futur...
Gespeichert in:
| Veröffentlicht in: | Front Aging Neurosci |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6966240/ https://ncbi.nlm.nih.gov/pubmed/31998120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2019.00373 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|